Patents by Inventor Marc R. REBOLL

Marc R. REBOLL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MYELOID-DERIVED GROWTH FACTOR FOR USE IN TREATING OR PREVENTING FIBROSIS, HYPERTROPHY OR HEART FAILURE
    Publication number: 20230059560
    Abstract: The present invention relates to the protein myeloid-derived growth factor (MYDGF) or nucleic acids encoding said protein for use in treating or preventing fibrosis and hypertrophy. The present invention also relates to the protein MYDGF or nucleic acids encoding said protein for use in treating heart failure. The present invention also relates to vectors comprising the nucleic acid, host cells expressing the nucleic acid, and methods for use in treating fibrosis and hypertrophy, and for use in treating heart failure.
    Type: Application
    Filed: January 19, 2021
    Publication date: February 23, 2023
    Inventors: Kai Christoph WOLLERT, Mortimer KORF-KLINGEBIEL, Marc R. REBOLL, Anton PEKCEC